SOD1 and Parkinson disease: In another study, CS-NPs loaded with pramipexole dihydrochloride (P-CS NPs), a drug currently used to treat Parkinson’s symptoms, enhanced the antioxidant status by increasing the enzymatic activities of SOD and catalase in addition to elevating dopamine levels in the brain of male Sprague–Dawley rats [151].